Metabolic syndrome worsens perioperative and oncological outcomes in patients with pancreatic ductal adenocarcinoma after R0 resection: A multicenter propensity score-matched study
{{output}}
Background: Metabolic syndrome (MS) influences the development of pancreatic ductal adenocarcinoma (PDAC), but its effect on oncological outcomes remains unclear. This study aimed to investigate the role of MS in the patients' p... ...
